Bailey MA et al. (2006). Maxi-K channels contribute to urinary potassium excretion in the ROMK-deficient mouse model of Type II Bartter's syndrome and in adaptation to a high-K diet. Kidney international. 70 [PubMed]
Baulac M. (2006). Introduction to zonisamide. Epilepsy research. 68 Suppl 2 [PubMed]
Butler A, Tsunoda S, McCobb DP, Wei A, Salkoff L. (1993). mSlo, a complex mouse gene encoding "maxi" calcium-activated potassium channels. Science (New York, N.Y.). 261 [PubMed]
Castro PA, Cooper EC, Lowenstein DH, Baraban SC. (2001). Hippocampal heterotopia lack functional Kv4.2 potassium channels in the methylazoxymethanol model of cortical malformations and epilepsy. The Journal of neuroscience : the official journal of the Society for Neuroscience. 21 [PubMed]
Du W et al. (2005). Calcium-sensitive potassium channelopathy in human epilepsy and paroxysmal movement disorder. Nature genetics. 37 [PubMed]
Ermentrout GB. (2002). Simulating, Analyzing, and Animating Dynamical System: A Guide to XPPAUT for Researchers and Students Society for Industrial and Applied Mathematics (SIAM).
Ghaemi SN et al. (2006). An open prospective study of zonisamide in acute bipolar depression. Journal of clinical psychopharmacology. 26 [PubMed]
Ghatta S, Nimmagadda D, Xu X, O'Rourke ST. (2006). Large-conductance, calcium-activated potassium channels: structural and functional implications. Pharmacology & therapeutics. 110 [PubMed]
Gribkoff VK et al. (2001). Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels. Nature medicine. 7 [PubMed]
Hong KW et al. (2003). Cilostazol prevents tumor necrosis factor-alpha-induced cell death by suppression of phosphatase and tensin homolog deleted from chromosome 10 phosphorylation and activation of Akt/cyclic AMP response element-binding protein phosphorylation. The Journal of pharmacology and experimental therapeutics. 306 [PubMed]
Huang CW, Huang CC, Liu YC, Wu SN. (2004). Inhibitory effect of lamotrigine on A-type potassium current in hippocampal neuron-derived H19-7 cells. Epilepsia. 45 [PubMed]
Huang CW, Huang CC, Wu SN. (2006). The opening effect of pregabalin on ATP-sensitive potassium channels in differentiated hippocampal neuron-derived H19-7 cells. Epilepsia. 47 [PubMed]
Huang CW, Ueno S, Okada M, Kaneko S. (2005). Zonisamide at clinically relevant concentrations inhibits field EPSP but not presynaptic fiber volley in rat frontal cortex. Epilepsy research. 67 [PubMed]
Jang IS, Nakamura M, Ito Y, Akaike N. (2006). Presynaptic GABAA receptors facilitate spontaneous glutamate release from presynaptic terminals on mechanically dissociated rat CA3 pyramidal neurons. Neuroscience. 138 [PubMed]
Kim B, Leventhal PS, Saltiel AR, Feldman EL. (1997). Insulin-like growth factor-I-mediated neurite outgrowth in vitro requires mitogen-activated protein kinase activation. The Journal of biological chemistry. 272 [PubMed]
Knaus HG et al. (1994). Tremorgenic indole alkaloids potently inhibit smooth muscle high-conductance calcium-activated potassium channels. Biochemistry. 33 [PubMed]
Laumonnier F et al. (2006). Association of a functional deficit of the BKCa channel, a synaptic regulator of neuronal excitability, with autism and mental retardation. The American journal of psychiatry. 163 [PubMed]
Leppik IE. (2004). Zonisamide: chemistry, mechanism of action, and pharmacokinetics. Seizure. 13 Suppl 1 [PubMed]
Morita S, Miwa H, Kondo T. (2005). Effect of zonisamide on essential tremor: a pilot crossover study in comparison with arotinolol. Parkinsonism & related disorders. 11 [PubMed]
Morrione A et al. (2000). Insulin-like growth factor I receptor signaling in differentiation of neuronal H19-7 cells. Cancer research. 60 [PubMed]
Ondo WG. (2006). Essential tremor: treatment options. Current treatment options in neurology. 8 [PubMed]
Oommen KJ, Mathews S. (2004). Zonisamide: a new antiepileptic drug. Clin Neuropharmacol. 22
Ortiz MI, Castañeda-Hernández G, Granados-Soto V. (2003). Possible involvement of potassium channels in peripheral antinociception induced by metamizol: lack of participation of ATP-sensitive K+ channels. Pharmacology, biochemistry, and behavior. 74 [PubMed]
Ortiz MI, Castañeda-Hernández G, Granados-Soto V. (2005). Pharmacological evidence for the activation of Ca2+-activated K+ channels by meloxicam in the formalin test. Pharmacology, biochemistry, and behavior. 81 [PubMed]
Peters DH, Sorkin EM. (1993). Zonisamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy. Drugs. 45 [PubMed]
Pinsky PF, Rinzel J. (1994). Intrinsic and network rhythmogenesis in a reduced Traub model for CA3 neurons. Journal of computational neuroscience. 1 [PubMed]
Rock DM, Macdonald RL, Taylor CP. (1989). Blockade of sustained repetitive action potentials in cultured spinal cord neurons by zonisamide (AD 810, CI 912), a novel anticonvulsant. Epilepsy research. 3 [PubMed]
Schauf CL. (1987). Zonisamide enhances slow sodium inactivation in Myxicola. Brain research. 413 [PubMed]
Shao LR, Halvorsrud R, Borg-Graham L, Storm JF. (1999). The role of BK-type Ca2+-dependent K+ channels in spike broadening during repetitive firing in rat hippocampal pyramidal cells. The Journal of physiology. 521 Pt 1 [PubMed]
Smith BL, McLeay LM, Embling PP. (1997). Effect of the mycotoxins penitrem, paxilline and lolitrem B on the electromyographic activity of skeletal and gastrointestinal smooth muscle of sheep. Research in veterinary science. 62 [PubMed]
Storm JF. (1990). Potassium currents in hippocampal pyramidal cells. Progress in brain research. 83 [PubMed]
Suzuki S et al. (1992). Zonisamide blocks T-type calcium channel in cultured neurons of rat cerebral cortex. Epilepsy research. 12 [PubMed]
Tanabe M, Sakaue A, Takasu K, Honda M, Ono H. (2005). Centrally mediated antihyperalgesic and antiallodynic effects of zonisamide following partial nerve injury in the mouse. Naunyn-Schmiedeberg's archives of pharmacology. 372 [PubMed]
Tasaki K et al. (1995). Drug interactions of zonisamide with phenytoin and sodium valproate: serum concentrations and protein binding. Brain & development. 17 [PubMed]
Tricarico D, Barbieri M, Mele A, Carbonara G, Camerino DC. (2004). Carbonic anhydrase inhibitors are specific openers of skeletal muscle BK channel of K+-deficient rats. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 18 [PubMed]
Wu SN, Chang HD. (2006). Diethyl pyrocarbonate, a histidine-modifying agent, directly stimulates activity of ATP-sensitive potassium channels in pituitary GH(3) cells. Biochemical pharmacology. 71 [PubMed]
Wu SN, Li HF. (1999). Characterization of riluzole-induced stimulation of large-conductance calcium-activated potassium channels in rat pituitary GH3 cells. Journal of investigative medicine : the official publication of the American Federation for Clinical Research. 47 [PubMed]
Wu SN, Liu SI, Huang MH. (2004). Cilostazol, an inhibitor of type 3 phosphodiesterase, stimulates large-conductance, calcium-activated potassium channels in pituitary GH3 cells and pheochromocytoma PC12 cells. Endocrinology. 145 [PubMed]
Wu SN, Wu AZ, Lin MW. (2006). Pharmacological roles of the large-conductance calcium-activated potassium channel. Current topics in medicinal chemistry. 6 [PubMed]
Yoshida S, Okada M, Zhu G, Kaneko S. (2005). Effects of zonisamide on neurotransmitter exocytosis associated with ryanodine receptors. Epilepsy research. 67 [PubMed]
Huang CW, Huang CC, Lin MW, Tsai JJ, Wu SN. (2008). The synergistic inhibitory actions of oxcarbazepine on voltage-gated sodium and potassium currents in differentiated NG108-15 neuronal cells and model neurons. The international journal of neuropsychopharmacology. 11 [PubMed]
Huang CW, Tsai JJ, Huang CC, Wu SN. (2009). Experimental and simulation studies on the mechanisms of levetiracetam-mediated inhibition of delayed-rectifier potassium current (KV3.1): contribution to the firing of action potentials. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society. 60 [PubMed]